---
category: news
title: "POAI Subsidiary Helomics Continues Progress Towards Goal of Developing an AI-Driven Predictive Model of Ovarian Cancer"
excerpt: "Predictive Oncology Inc. (NASDAQ: POAI) (“POAI” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced continued progress towards by its Helomics subsidiary towards the goal of developing an AI-driven predictive model of ovarian cancer (CancerQuest 2020)."
publishedDateTime: 2020-04-11T21:27:00Z
webUrl: "https://apnews.com/Globe Newswire/8c5feda325eb33f5192dcda63d88839e"
type: article
quality: 15
heat: 15
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    title: "POAI Subsidiary Helomics Continues Progress Towards Goal of Developing an AI-Driven Predictive Model of Ovarian Cancer"

secured: "kLz1MSefl8aM7HLMt87cS36pGT+xunjP58YnAJ/ZuF4ol7Bvp+37FltUdkpPKTHd+rY2Xr4SZcDV/zkEGRJUaFoawZzHAfsk+dagXcq9W3/n4K4HbIfTmj2kXXwh2P4dDFSnS/C53DEcqJ+5kak1rRQHXjetfLo9yHp3LhLxWGnjWE/Sb+OUdURp9VE51QCVxy+sI+6ExXLC4ypHcsgQIhJncYwDBdIi6h62lpOmehptn9rOcWAJSSv/jDpoXOG4ikL4/vLNjjQNrQ4FGQIHX4lm1J6/CWPmwQtzmES6XMXBaTDxuCNlVL0xL6/P5fOX;Tf69CJPpNb2caI+vKZEWeQ=="
---

